(Note: the fusion was discovered by NGS. Many chromosome rearrangement mechanisms such as translocation, inversion,deletion or complex rearrangement may lead to the same fusion)
Note
Non-annotated chromosomal abnormality. Preliminary data :
if you are an author who wish to write a full paper/card on this translocation,go to u00a0How to contribute
Summary
Note
Non-annotated chromosomal abnormality. Preliminary data :
if you are an author who wish to write a full paper/card on this translocation,go to How to contribute
if you are an author who wish to write a full paper/card on this translocation,go to How to contribute
Highly cited references
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 29654229 | 2018 | Somatic genome editing with the RCAS-TVA-CRISPR-Cas9 system for precision tumor modeling. | 73 |
| 34863095 | 2021 | Discovery of clinically relevant fusions in pediatric cancer. | 60 |
| 28695888 | 2017 | Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target. | 37 |
| 29872694 | 2017 | Clinical and radiographic response following targeting of BCAN-NTRK1 fusion in glioneuronal tumor. | 26 |
| 29532792 | 2018 | Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target. | 0 |
Article Bibliography
| Pubmed ID | Last Year | Title | Authors |
|---|---|---|---|
| 23917401 | 2013 | The integrated landscape of driver genomic alterations in glioblastoma. | Frattini V et al |
| 24261984 | 2013 | Exploration of the gene fusion landscape of glioblastoma using transcriptome sequencing and copy number data. | Shah N et al |
Citation
Jean-Loup Huret ; Philippe Dessen
BCAN/NTRK1 (1q23)
Atlas Genet Cytogenet Oncol Haematol. 0000-00-00
Online version: http://atlasgeneticsoncology.org/solid-tumor/103943/bcan-ntrk1-(1q23)
